BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7037033)

  • 1. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
    Pritchard J; McElwain TJ; Graham-Pole J
    Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
    Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
    Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.
    Hartmann O; Kalifa C; Benhamou E; Patte C; Flamant F; Jullien C; Beaujean F; Lemerle J
    Cancer Chemother Pharmacol; 1986; 16(2):165-9. PubMed ID: 3512113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
    Gordon SJ; Pearson AD; Reid MM; Craft AW
    Eur J Cancer; 1992; 28A(8-9):1319-23. PubMed ID: 1515242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.
    Pritchard J; Cotterill SJ; Germond SM; Imeson J; de Kraker J; Jones DR
    Pediatr Blood Cancer; 2005 Apr; 44(4):348-57. PubMed ID: 15546135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
    Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
    Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
    Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
    Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
    Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.
    Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N
    J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
    Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
    Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved prognosis for children with stage IV neuroblastoma: high-dose melphalan and autologous unpurged marrow transplantation after aggressive surgery and short chemotherapy with cisplatinum and etoposide.
    Rajantie J; Wikström S; Perkkiö M; Hovi L; Mäkipernaa A; Maunuksela EL; Siimes MA
    Pediatr Hematol Oncol; 1988; 5(2):125-35. PubMed ID: 3152958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
    Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
    Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan.
    Kingston JE; Malpas JS; Stiller CA; Pritchard J; McElwain TJ
    Br J Haematol; 1984 Dec; 58(4):589-95. PubMed ID: 6394042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.